natgillin/translations-raw huggingface dataset:
A fertility study in female rats has shown adverse reproductive effects.
Istraživanje plodnosti na ženkama štakora pokazalo je štetne učinke na reprodukciju.
Effective contraception must be used by women of child-bearing potential.
Žene reproduktivne dobi moraju koristiti učinkovitu kontracepciju.
It is important to take your Pregabalin Mylan Pharma capsules regularly at the same time each day.
Ako ste zaboravili uzeti lijek Pregabalin Mylan Pharma Važno je da Pregabalin Mylan Pharma kapsule uzimate redovito, svakoga dana u isto vrijeme.
After discontinuation of short-term and long-term treatment with pregabalin, withdrawal symptoms have been observed in some patients.
Nakon prekida kratkotrajnog i dugotrajnog liječenja pregabalinom u nekih su bolesnika opaženi simptomi ustezanja.
• Dilated pupils, cross eyes
• proširene zjenice, ukrižene oči
In the clinical studies where ophthalmologic testing was conducted, the incidence of visual acuity reduction and visual field changes was greater in pregabalin-treated patients than in placebo-treated patients; the incidence of fundoscopic changes was greater in placebo-treated patients (see section 5.1).
U kliničkim ispitivanjima u kojima su provedene oftalmološke pretrage, smanjenje oštrine vida i promjene vidnog polja javljali su se s većom incidencijom u bolesnika liječenih pregabalinom nego u bolesnika koji su primali placebo; incidencija promjena očne pozadine bila je veća u bolesnika koji su primali placebo (vidjeti dio 5.1).
Bottle: Keep the bottle tightly closed in order to protect from moisture.
Boca: čuvati bocu dobro zatvorenom radi zaštite od vlage.
When taken with certain other medicines, Pregabalin Mylan Pharma may potentiate the side effects seen with these medicines, including respiratory failure and coma.
Kada se uzima s nekim drugim lijekovima, Pregabalin Mylan Pharma može pojačati nuspojave tih lijekova, uključujući zatajenje disanja i komu.
Pregabalin Mylan Pharma is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
Pregabalin Mylan Pharma je indiciran kao dodatna terapija u odraslih osoba s parcijalnim napadajima, sa ili bez sekundarne generalizacije.
Adverse effects on fertility in male and female rats were only observed at exposures sufficiently in excess of therapeutic exposure.
Štetni učinci na plodnost mužjaka i ženki štakora opaženi su samo pri izloženosti dovoljno većoj od terapijske izloženosti.
Starting dose (mg/day)
Početna doza (mg/dan)
Should you experience any of these reactions, you should contact your physician immediately.
Ako se pojavi neka od tih reakcija, morate se odmah javiti svom liječniku.
Central nervous system influencing medical products Pregabalin may potentiate the effects of ethanol and lorazepam.
Pregabalin može pojačati učinke etanola i lorazepama.
Pregabalin plasma clearance and renal clearance are directly proportional to creatinine clearance (see section 5.2 Renal impairment).
Klirens pregabalina iz plazme i bubrežni klirens upravo su razmjerni klirensu kreatinina (vidjeti dio 5.2, Oštećenje bubrega).
• Pregabalin Mylan Pharma has been associated with dizziness and somnolence, which could increase the occurrence of accidental injury (fall) in elderly patients.
• Liječenje lijekom Pregabalin Mylan Pharma povezuje se s pojavom omaglice i pospanosti, što može povećati broj slučajnih ozljeda (padova) u starijih bolesnika.
Visual field changes were detected in 12.4% of pregabalin-treated, and 11.7% of placebo-treated patients.
Promjene vidnog polja utvrđene su u 12,4% bolesnika liječenih pregabalinom i 11,7% bolesnika koji su primali placebo.
Pregabalin is eliminated from the systemic circulation primarily by renal excretion as unchanged drug.
Pregabalin se iz sustavne cirkulacije primarno odstranjuje izlučivanjem nepromijenjenog lijeka putem bubrega.
GAD can also cause restlessness or feeling keyed up or on edge, being easily fatigued (tired), having difficulty concentrating or mind going blank, feeling irritable, having muscle tension or sleep disturbance.
GAP može uzrokovati i nemir ili osjećaj napetosti ili bezizlaznosti, brzo iscrpljivanje (umaranje), poteškoće s koncentracijom ili prisjećanjem, razdražljivost, napetost mišića ili poremećaj spavanja.
Infections and infestations Common
Infekcije i infestacije Često nazofaringitis
What you need to know before you take Pregabalin Mylan Pharma 3.
Što morate znati prije nego počnete uzimati Pregabalin Mylan Pharma 3.
Tachycardia, atrioventricular block first degree, sinus bradycardia, congestive heart failure
Srčani poremećaji Manje često tahikardija, atrioventrikularni blok prvog stupnja, sinusna bradikardija, kongestivno zatajenje srca
Convulsion, parosmia, hypokinesia, dysgraphia
Rijetko konvulzije, parosmija, hipokinezija, disgrafija
Pregabalin undergoes negligible metabolism in humans.
Metabolizam pregabalina u ljudi je zanemariv.
In controlled clinical trials, multiple oral doses of pregabalin co-administered with oxycodone, lorazepam, or ethanol did not result in clinically important effects on respiration.
U kontroliranim kliničkim ispitivanjima primjena višekratnih peroralnih doza pregabalina istodobno s oksikodonom, lorazepamom ili etanolom nije izazvala klinički važne učinke na disanje.
Since pregabalin is predominantly excreted unchanged in the urine, undergoes negligible metabolism in humans (<2% of a dose recovered in urine as metabolites), does not inhibit drug metabolism in vitro, and is not bound to plasma proteins, it is unlikely to produce, or be subject to, pharmacokinetic interactions.
(< 2% doze pronađe se u mokraći u obliku metabolita), da ne inhibira metabolizam lijekova in vitro i ne veže se za proteine u plazmi, nije vjerojatno da će izazivati ili ulaziti u farmakokinetičke interakcije.
Generalised Anxiety Disorder: Pregabalin Mylan Pharma is used to treat Generalised Anxiety Disorder (GAD).
Generalizirani anksiozni poremećaj: Pregabalin Mylan Pharma se koristi za liječenje generaliziranog anksioznog poremećaja (GAP).
C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION
OSTALI UVJETI I ZAHTJEVI ZA STAVLJANJE LIJEKA U PROMET
Since pregabalin does not undergo significant metabolism and is excreted predominantly as unchanged drug in the urine, impaired liver function would not be expected to significantly alter pregabalin plasma concentrations.
Budući da metabolizam pregabalina nije značajan te da se pretežno izlučuje mokraćom u nepromijenjenom obliku, nije vjerojatno da će oštećenje jetrene funkcije značajno promijeniti koncentracije pregabalina u plazmi.
• Feeling of elation, confusion, disorientation, decrease in sexual interest, irritability
• ushićenje, smetenost, dezorijentiranost, smanjenje seksualne želje, razdražljivost
Funduscopic changes were observed in 1.7% of pregabalin-treated and 2.1% of placebo-treated patients.
Promjene očne pozadine opažene su u 1,7% bolesnika liječenih pregabalinom i 2,1% bolesnika koji su primali placebo.
Pregabalin Mylan Pharma may cause dizziness and somnolence and therefore may influence the ability to drive or use machines.
Pregabalin Mylan Pharma može izazvati omaglicu i somnolenciju te tako utjecati na sposobnost upravljanja vozilima ili rada sa strojevima.
In the post-marketing experience, the most commonly reported adverse reactions observed when pregabalin was taken in overdose included somnolence, confusional state, agitation, and restlessness.
Nakon stavljanja lijeka u promet najčešće prijavljene nuspojave kod predoziranja pregabalinom uključuju somnolenciju, stanje konfuzije, agitaciju i nemir.
Pregabalin should be discontinued immediately if symptoms of angioedema, such as facial, perioral, or upper airway swelling occur.
Primjenu pregabalina treba odmah prekinuti ako nastupe simptomi angioedema, kao što su oticanje lica, područja oko usta ili gornjih dišnih puteva.
BGP Products SIA Tel: +371 676 055 80
BGP Products SIA Tel: +371 676 055 80 (Lielbritānija)
• Muscle twitching, joint swelling, muscle stiffness, pain including muscle pain, neck pain
• trzanje mišića, oticanje zglobova, ukočenost mišića, bol uključujući bol u mišićima, bol u vratu
The most common adverse reactions resulting in discontinuation from pregabalin treatment groups were dizziness and somnolence.
Najčešće nuspojave zbog kojih je prekinuto liječenje u skupinama koje su primale pregabalin bile su omaglica i somnolencija.
NAME OF THE MEDICINAL PRODUCT
1. NAZIV LIJEKA
Other medicines and Pregabalin Mylan Pharma Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Obavijestite svog liječnika ili ljekarnika ako uzimate ili ste nedavno uzeli ili biste mogli uzeti bilo koje druge lijekove.
Relief of the symptoms of GAD as reflected by the Hamilton Anxiety Rating Scale (HAM-A) was observed by Week 1.
Hamilton Anxiety Rating Scale, HAM-A) opaženo je u prvom tjednu liječenja.
A reduction in seizure frequency was observed by Week 1.
Smanjenje učestalosti napadaja opaženo je u prvom tjednu liječenja.
HDPE bottle pack containing 200 hard capsules.
Boca od polietilena visoke gustoće (HDPE) koja sadrži 200 tvrdih kapsula.
Pregabalin dose adjustment based on renal function
Tablica 1: Prilagodba doze pregabalina na temelju funkcije bubrega
Euphoric mood, confusion, irritability, disorientation, insomnia, libido decreased
Često euforično raspoloženje, konfuzija, razdražljivost, dezorijentacija, nesanica, smanjen libido
Additional reactions reported from post-marketing experience are included in italics in the list below.
Dodatne nuspojave prijavljene nakon stavljanja lijeka u promet u Tablici ispod su navedene kurzivom.
Foetal toxicity in rats and rabbits occurred only at exposures sufficiently above human exposure.
Fetotoksičnost je u štakora i kunića nastupila samo pri izloženosti dovoljno većoj od izloženosti u ljudi.
• Breast discharge, abnormal breast growth, breast growth in males
• iscjedak iz dojke, neuobičajen rast dojki, rast dojki u muškaraca
The degree of dizziness, sleepiness and decreased concentration may be increased if Pregabalin Mylan Pharma is taken together with medicinal products containing:
Omaglica, pospanost i smanjenje koncentracije mogu se pojačati ako se Pregabalin Mylan Pharma uzima zajedno s lijekovima koji sadrže: Oksikodon - (koristi se protiv bolova)
• Blurred vision, double vision
• zamagljen vid, dvoslike
Very rare: may affect up to 1 in 10,000 people
Vrlo rijetke: mogu se javiti u do 1 na 10 000 osoba
Overall, the safety and efficacy profiles for BID and TID dosing regimens were similar.
Profili sigurnosti i djelotvornosti za režime doziranja dva puta na dan i tri puta na dan općenito su bili podjednaki.
Withdrawal of concomitant anti-epileptic medicinal products There are insufficient data for the withdrawal of concomitant anti-epileptic medicinal products, once seizure control with pregabalin in the add-on situation has been reached, in order to reach monotherapy on pregabalin.
Nema dovoljno podataka za ukidanje istodobno primijenjenih antiepileptika nakon što je dodavanjem pregabalina postignuta kontrola napadaja, a u cilju monoterapije pregabalinom.
Pregabalin Mylan Pharma is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.
Pregabalin Mylan Pharma je indicirana za liječenje generaliziranog anksioznog poremećaja (GAP) u odraslih osoba.
Single dose+
jedna doza
Pregabalin has been studied in 3 controlled clinical trials of 12 week duration with either BID or TID dosing.
Pregabalin je ispitan u 3 kontrolirana klinička ispitivanja u trajanju od 12 tjedana, s režimom doziranja dva puta na dan ili tri puta na dan.
Pregabalin Mylan Pharma may have minor or moderate influence on the ability to drive and use machines.
Pregabalin Mylan Pharma može malo ili umjereno utjecati na sposobnost upravljanja vozilima i rada sa strojevima.
Lactation had little to no influence on pregabalin pharmacokinetics.
Dojenje nije utjecalo ili je zanemarivo utjecalo na farmakokinetiku pregabalina.
Pregabalin has been studied in 1 controlled clinical trial of 56 week duration with BID dosing.
Pregabalin je ispitan u jednom kontroliranom kliničkom ispitivanju u trajanju od 56 tjedana, s režimom doziranja dva puta na dan.
Ataxia, coordination abnormal, tremor, dysarthria, amnesia, memory impairment, disturbance in attention, paraesthesia, hypoaesthesia, sedation, balance disorder, lethargy
Često ataksija, poremećaj koordinacije, tremor, dizartrija, amnezija, poremećaj pamćenja, poremećaj pažnje, parestezija, hipoestezija, sedacija, poremećaj ravnoteže, letargija
In the post-marketing experience, there are reports of respiratory failure and coma in patients taking pregabalin and other central nervous system (CNS) depressant medicinal products.
Nakon stavljanja lijeka u promet, u bolesnika koji su uzimali pregabalin i druge depresore središnjeg živčanog sustava (SŽS) prijavljeni su zatajenje disanja i koma.
In all controlled studies, the discontinuation rate due to adverse reactions was 12% for patients receiving pregabalin and 5% for patients receiving placebo.
U svim je kontroliranim kliničkim ispitivanjima udio bolesnika koji su prekinuli liječenje zbog nuspojava iznosio 12% među bolesnicima koji su primali pregabalin te 5% među bolesnicima koji su primali placebo.
Mylan Ireland Tel: +353 (0) 87 1694982
Tel: +353 (0) 87 1694982
Blood creatine phosphokinase increased, blood glucose increased, platelet count decreased, blood creatinine increased, blood potassium decreased, weight decreased
Manje često povećanje kreatin fosfokinaze u krvi, povećanje glukoze u krvi, smanjenje broja trombocita, povećanje kreatinina u krvi, snižene vrijednosti kalija u krvi, smanjenje tjelesne težine
Psychiatric disorders Common
Psihijatrijski poremećaji
• Weakness, thirst, chest tightness
• slabost, žeđ, stezanje u prsištu
Manufacturer
Proizvođač:
• Sweating, rash, chills, fever
• znojenje, osip, zimica, vrućica
What Pregabalin Mylan Pharma contains
Što Pregabalin Mylan Pharma sadrži
• Certain side effects may be more common, such as sleepiness, because patients with spinal cord injury may be taking other medicines to treat, for example, pain or spasticity, that have similar side effects to Pregabalin and the severity of these effects may be increased when taken together.
• Neke nuspojave, poput pospanosti, mogu se javljati češće jer bolesnici s ozljedom leđne moždine možda uzimaju druge lijekove za liječenje, primjerice, boli ili grčeva, koji imaju slične nuspojave kao pregabalin.
SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN
6. POSEBNO UPOZORENJE O ČUVANJU LIJEKA IZVAN POGLEDA
Syncope, stupor, myoclonus, loss of consciousness, psychomotor hyperactivity, dyskinesia, dizziness postural, intention tremor, nystagmus, cognitive disorder, mental impairment, speech disorder, hyporeflexia, hyperaesthesia, burning sensation, ageusia, malaise
Manje često sinkopa, stupor, mioklonus, gubitak svijesti, psihomotorička hiperaktivnost, diskinezija, posturalna omaglica, intencijski tremor, nistagmus, kognitivni poremećaj, slabljenje mentalnih sposobnosti, poremećaj govora, hiporefleksija, hiperestezija, osjećaj žarenja, ageuzija, malaksalost
• Change in perception of self, restlessness, depression, agitation, mood swings, difficulty finding words, hallucinations, abnormal dreams, panic attacks, apathy, aggression, elevated mood, mental impairment, difficulty with thinking, increase in sexual interest, problems with sexual functioning including inability to achieve a sexual climax, delayed ejaculation
• promijenjena slika o sebi, nemir, depresija, uznemirenost, promjene raspoloženja, poteškoće u pronalaženju riječi, halucinacije, neuobičajeni snovi, napadaj panike, apatija, agresija, povišeno raspoloženje, slabljenje mentalnih sposobnosti, poteškoće pri razmišljanju, povećanje seksualne želje, tegobe sa spolnom funkcijom uključujući nemogućnost postizanja orgazma, odgođena ejakulacija
Hallucination, panic attack, restlessness, agitation, depression, depressed mood, elevated mood, aggression, mood swings, depersonalisation, word finding difficulty, abnormal dreams, libido increased, anorgasmia, apathy
Manje često halucinacije, napad panike, nemir, agitacija, depresija, depresivno raspoloženje, povišeno raspoloženje, agresija, promjene raspoloženja, depersonalizacija, poteškoće u pronalaženju riječi, neuobičajeni snovi, pojačan libido, anorgazmija, apatija
Rare: may affect up to 1 in 1,000 people
Rijetke: mogu se javiti u do 1 na 1000 osoba
Pregabalin Mylan Pharma 25 mg hard capsules Pregabalin Mylan Pharma 50 mg hard capsules Pregabalin Mylan Pharma 75 mg hard capsules Pregabalin Mylan Pharma 100 mg hard capsules Pregabalin Mylan Pharma 150 mg hard capsules Pregabalin Mylan Pharma 200 mg hard capsules Pregabalin Mylan Pharma 225 mg hard capsules Pregabalin Mylan Pharma 300 mg hard capsules
Pregabalin Mylan Pharma 25 mg tvrde kapsule Pregabalin Mylan Pharma 50 mg tvrde kapsule Pregabalin Mylan Pharma 75 mg tvrde kapsule Pregabalin Mylan Pharma 100 mg tvrde kapsule Pregabalin Mylan Pharma 150 mg tvrde kapsule Pregabalin Mylan Pharma 200 mg tvrde kapsule Pregabalin Mylan Pharma 225 mg tvrde kapsule Pregabalin Mylan Pharma 300 mg tvrde kapsule pregabalin
The incidence of adverse reactions in general, CNS adverse reactions and especially somnolence was increased in the treatment of central neuropathic pain due to spinal cord injury (see section
Incidencija nuspojava općenito te nuspojava SŽS-a i osobito somnolencije bila je povećana pri liječenju centralne neuropatske boli uzrokovane ozljedom leđne moždine (vidjeti dio 4.4).
Certain side effects may be more common, such as sleepiness, because patients with spinal cord injury may be taking other medicines to treat, for example, pain or spasticity, that have similar side effects to Pregabalin and the severity of these effects may be increased when taken together.
Neke nuspojave, poput pospanosti, mogu se javljati češće jer bolesnici s ozljedom leđne moždine možda uzimaju druge lijekove za liječenje, primjerice, boli ili grčeva, koji imaju slične nuspojave kao pregabalin.
Adverse reactions in patients with spinal cord injury The incidence of adverse reactions in general, central nervous system adverse reactions and especially somnolence was increased in the treatment of central neuropathic pain due to spinal cord injury.
Incidencija nuspojava općenito te nuspojava središnjeg živčanog sustava i osobito somnolencije bila je povećana pri liječenju centralne neuropatske boli uzrokovane ozljedom leđne moždine.
• Abnormal sense of smell, swinging vision, altered perception of depth, visual brightness,
• neuobičajen osjet mirisa, nemogućnost fokusiranja slike, promijenjena percepcija dubine,
Blister: Store in the original package in order to protect from moisture.
Blister:čuvati u originalnom pakiranju radi zaštite od vlage.
Appetite increased Anorexia, hypoglycaemia
Manje često anoreksija, hipoglikemija
Erectile dysfunction
Često erektilna disfunkcija
SPECIAL STORAGE CONDITIONS Keep the bottle tightly closed in order to protect from moisture.
POSEBNE MJERE ČUVANJA Čuvati bočicu dobro zatvorenom radi zaštite od vlage.
Cases of renal failure have been reported and in some cases discontinuation of pregabalin did show reversibility of this adverse reaction.
Prijavljeni su slučajevi zatajenja bubrega, a u nekim se slučajevima nakon prekida primjene pregabalina ova nuspojava povukla.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA
Weight increased
• porast tjelesne težine
• There have been reports of heart failure in some patients when taking Pregabalin Mylan Pharma; these patients were mostly elderly with cardiovascular conditions.
• U nekih je bolesnika pri uzimanju lijeka Pregabalin Mylan Pharma prijavljeno zatajenje srca; radilo se uglavnom o starijim bolesnicima s postojećim bolestima srca i krvožilja.
• Kidney failure, reduced urine volume, urinary retention
• zatajenje bubrega, smanjen volumen mokraće, zadržavanje mokraće
• Allergic reactions (which may include difficulty breathing, inflammation of the eyes
• alergijske reakcije (koje mogu obuhvaćati otežano disanje, upalu očiju (keratitis) i ozbiljne kožne reakcije koje obilježavaju osip, mjehurići, ljuštenje kože i bol)
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING BOTTLE LABEL
PODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKIRANJU NALJEPNICA NA BOCI
• Flushing, hot flushes
• navale crvenila, navale vrućine
Do not take Pregabalin Mylan Pharma: If you are allergic to pregabalin or any of the other ingredients of this medicine (listed in section 6).
• Ako ste alergični na pregabalin ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.).
How to store Pregabalin Mylan Pharma 6.
Kako čuvati Pregabalin Mylan Pharma 6.
Pregabalin treatment can be started with a dose of 150 mg per day given as two or three divided doses.
Liječenje pregabalinom može započeti dozom od 150 mg na dan, podijeljenom u dvije ili tri doze.
• Dry eyes, eye swelling, eye pain, weak eyes, watery eyes, eye irritation
• suhe oči, oticanje očiju, bol u oku, slabost očiju, suzne oči, nadraženost očiju
Reduced acoustic startle response was observed in juvenile rats 1-2 weeks after exposure at >2 times the human therapeutic exposure.
U mladih je štakora nakon 1-2 tjedna izloženosti > 2 puta većoj od terapijske izloženosti u ljudi opažena umanjena reakcija straha na akustične podražaje.
Sexual dysfunction, ejaculation delayed, dysmenorrhoea, breast pain
Manje često seksualna disfunkcija, odgođena ejakulacija, dismenoreja, bol u dojci
After stopping long and short-term Pregabalin Mylan Pharma treatment, you need to know that you may experience certain side effects.
Morate znati da nakon prekida dugotrajnog i kratkotrajnog liječenja lijekom Pregabalin Mylan Pharma mogu nastupiti određene nuspojave.
What Pregabalin Mylan Pharma is and what it is used for Pregabalin Mylan Pharma contains the active substance pregabalin which belongs to a group of medicines used to treat epilepsy and Generalised Anxiety Disorder (GAD) in adults.
Pregabalin Mylan Pharma sadrži djelatnu tvar pregabalin koja pripada skupini lijekova koji se koriste za liječenja epilepsije i generaliziranog anksioznog poremećaja (GAP) u odraslih osoba.
Iron oxide black (E172) Macrogol
Tinta za označavanje šelak željezov oksid, crni (E172) Macrogol otopina amonijaka, koncentrirana kalijev hidroksid
You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Nuspojave možete prijaviti izravno putem nacionalnog sustava za prijavu nuspojava navedenog u Dodatku V*.
METHOD AND ROUTE(S) OF ADMINISTRATION Read the package leaflet before use.
5. NAČIN I PUT(EVI) PRIMJENE LIJEKA Prije uporabe pročitajte Uputu o lijeku.
Hepatic impairment No dose adjustment is required for patients with hepatic impairment (see section 5.2).
Nije potrebno prilagođavati dozu u bolesnika s oštećenjem funkcije jetre (vidjeti dio 5.2).
SPECIAL STORAGE CONDITIONS Blister: Store in the original package in order to protect from moisture.
POSEBNE MJERE ČUVANJA Blister:čuvati u originalnom pakiranju radi zaštite od vlage.
Peripheral vision loss, visual disturbance, eye swelling, visual field defect, visual acuity reduced, eye pain, asthenopia, photopsia, dry eye, lacrimation increased, eye irritation
Manje često gubitak perifernog vida, poremećaj vida, oticanje oka, suženje vidnog polja, smanjena oštrina vida, bol u oku, astenopija, fotopsija, suho oko, pojačano suzenje, iritacija oka
Ear and labyrinth disorders Common
Poremećaji uha i labirinta Često vrtoglavica
Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics, ATC code: N03AX16.
Farmakoterapijska skupina: Antiepileptici, ostali antiepileptici; ATK oznaka: N03AX16 Djelatna tvar je pregabalin, analog gama-aminomaslačne kiseline [(S)-3-(aminometil)-5-metilheksanoična kiselina].
• Dry mouth, constipation, vomiting, flatulence, diarrhoea, nausea, swollen abdomen
• suha usta, zatvor, povraćanje, vjetrovi, proljev, mučnina, otečen trbuh
• Increased saliva production, heartburn, numb around mouth
• pojačano stvaranje sline, žgaravica, utrnulost oko usta
Withdrawal symptoms
Simptomi ustezanja